Search research articles
Contact Us
Filters
Showing results (121-130 of 317) with videos related to
Page
of 32
Sort By:
AIDS and Behavior
|
June 27, 2018
Comparisons of New HIV Rapid Test Kit Performance
Dennis G Fisher, Kristen L Hess, Grace L Reynolds, et al.
Cancers
|
February 15, 2022
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival
Lauren Pommert, Todd M Cooper, Robert B Gerbing, et al.
Blood
|
April 19, 2007
The incidence and clinical significance of nucleophosmin mutations in childhood AML
Patrick Brown, Emily McIntyre, Rachel Rau, et al.
Pediatric Blood & Cancer
|
April 20, 2011
Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group
Phoenix A Ho, Matthew A Kutny, Todd A Alonzo, et al.
Blood
|
June 26, 2004
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia
William Tse, Soheil Meshinchi, Todd A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 30, 2016
Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group
Robert B Gerbing, Todd A Alonzo, Lillian Sung, et al.
Journal of Affective Disorders
|
February 26, 2018
Clinical pilot study of transcranial direct current stimulation combined with Cognitive Emotional Training for medication resistant depression
D M Martin, J Z Teng, T Y Lo, et al.
Journal of Pediatric Hematology/Oncology
|
August 11, 2018
Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631
Madhvi Rajpurkar, Todd A Alonzo, Yi-Cheng Wang, et al.
Pediatric Blood & Cancer
|
June 18, 2011
Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia
Beverly J Lange, Richard K Yang, Jacek Gan, et al.
Pediatric Blood & Cancer
|
January 22, 2013
Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group
Todd M Cooper, Bassem I Razzouk, Robert Gerbing, et al.
Page
of 32
Search research articles
Search
Showing results (121-130 of 317) with videos related to
Sort By:
Page
of 32
AIDS and Behavior
|
June 27, 2018
Comparisons of New HIV Rapid Test Kit Performance
Dennis G Fisher, Kristen L Hess, Grace L Reynolds, et al.
Cancers
|
February 15, 2022
Blood Count Recovery Following Induction Therapy for Acute Myeloid Leukemia in Children Does Not Predict Survival
Lauren Pommert, Todd M Cooper, Robert B Gerbing, et al.
Blood
|
April 19, 2007
The incidence and clinical significance of nucleophosmin mutations in childhood AML
Patrick Brown, Emily McIntyre, Rachel Rau, et al.
Pediatric Blood & Cancer
|
April 20, 2011
Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group
Phoenix A Ho, Matthew A Kutny, Todd A Alonzo, et al.
Blood
|
June 26, 2004
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia
William Tse, Soheil Meshinchi, Todd A Alonzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 30, 2016
Shorter Remission Telomere Length Predicts Delayed Neutrophil Recovery After Acute Myeloid Leukemia Therapy: A Report From the Children's Oncology Group
Robert B Gerbing, Todd A Alonzo, Lillian Sung, et al.
Journal of Affective Disorders
|
February 26, 2018
Clinical pilot study of transcranial direct current stimulation combined with Cognitive Emotional Training for medication resistant depression
D M Martin, J Z Teng, T Y Lo, et al.
Journal of Pediatric Hematology/Oncology
|
August 11, 2018
Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631
Madhvi Rajpurkar, Todd A Alonzo, Yi-Cheng Wang, et al.
Pediatric Blood & Cancer
|
June 18, 2011
Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia
Beverly J Lange, Richard K Yang, Jacek Gan, et al.
Pediatric Blood & Cancer
|
January 22, 2013
Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group
Todd M Cooper, Bassem I Razzouk, Robert Gerbing, et al.
Page
of 32